New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 6, 2012
14:58 EDTNVONovo Nordisk volatility elevated into FDA Drugs Advisory Committee Meeting
Novo Nordisk November call option implied volatility is at 48, December is at 29, March is at 24; compared to its 26-week average of 26 according to Track Data, suggesting larger near term price movement into a FDA--CDER - Endocrinologic and Metabolic Drugs Advisory Committee Meeting on November 8.
News For NVO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 21, 2015
06:38 EDTNVONovo Nordisk rejects claims made by Baxter, Reuters says
Novo Nordisk (NVO) rejects claims made by Baxter (BAX) that the company used substances made by Baxter in its Novoeight haemophilia treatment, following Monday's ITC investigation announcement, reports Reuters, citing an email from Novo Nordisk. Reference Link
May 20, 2015
10:26 EDTNVOJanssen acquires licence from Novo Nordisk for autoimmune disease development
Novo Nordisk (NVO) announced it has signed an agreement with Janssen Biotech (JNJ) under which Janssen will acquire an exclusive global license to further develop and commercialize a clinical program focused on therapy within autoimmune diseases. The program targets modulation of certain immune cells via a cell surface receptor, specifically the NKG2D receptor. Terms of the agreement have not been disclosed.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use